These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9778333)

  • 1. Chronic amlodipine treatment during the development of heart failure.
    Spinale FG; Mukherjee R; Krombach RS; Clair MJ; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Zellner JL; Dodd MG
    Circulation; 1998 Oct; 98(16):1666-74. PubMed ID: 9778333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
    McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
    J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure.
    Kribbs SB; Merritt WM; Clair MJ; Krombach RS; Houck WV; Dodd MG; Mukherjee R; Spinale FG
    Hypertension; 1998 Mar; 31(3):755-65. PubMed ID: 9495258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain blood flow patterns after the development of congestive heart failure: effects of treadmill exercise.
    Caparas SN; Clair MJ; Krombach RS; Hendrick JW; Houck WV; Kribbs SB; Mukherjee R; Tempel GE; Spinale FG
    Crit Care Med; 2000 Jan; 28(1):209-14. PubMed ID: 10667524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
    New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
    Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function.
    King MK; Gay DM; Pan LC; McElmurray JH; Hendrick JW; Pirie C; Morrison A; Ding C; Mukherjee R; Spinale FG
    Circulation; 2001 Jan; 103(2):308-13. PubMed ID: 11208694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure.
    Houck WV; Pan LC; Kribbs SB; Clair MJ; McDaniel GM; Krombach RS; Merritt WM; Pirie C; Iannini JP; Mukherjee R; Spinale FG
    Circulation; 1999 Nov; 100(19):2003-9. PubMed ID: 10556227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
    Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
    J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.
    Spinale FG; Coker ML; Krombach SR; Mukherjee R; Hallak H; Houck WV; Clair MJ; Kribbs SB; Johnson LL; Peterson JT; Zile MR
    Circ Res; 1999 Aug; 85(4):364-76. PubMed ID: 10455065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
    Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
    Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Cavallo MJ; Child MJ; Spinale FG
    J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure.
    Hebbar L; Dorman BH; Clair MJ; Roy RC; Spinale FG
    Anesthesiology; 1997 Mar; 86(3):649-59. PubMed ID: 9066332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs.
    Thomas CV; McDaniel GM; Holzgrefe HH; Mukherjee R; Hird RB; Walker JD; Hebbar L; Powell JR; Spinale FG
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):902-12. PubMed ID: 9869495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
    Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
    J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
    Spinale FG; Coker ML; Thomas CV; Walker JD; Mukherjee R; Hebbar L
    Circ Res; 1998 Mar; 82(4):482-95. PubMed ID: 9506709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.